Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Dexcom Inc shares valued at $53,934 were sold by Malady Kyle on Sep 05 ’25. At $80.86 per share, Malady Kyle sold 667 shares. The insider’s holdings dropped to 22,667 shares worth approximately $1.72 million following the completion of this transaction.
Also, Stern Sadie sold 1,466 shares, netting a total of over 117,280 in proceeds. Following the sale of shares at $80.00 each, the insider now holds 105,223 shares.
Before that, Malady Kyle had added 667 shares to its account. In a trade valued at $53,934, the Director bought Dexcom Inc shares for $80.86 each.
As published in a research note from Oppenheimer on September 08, 2025, Dexcom Inc [DXCM] has been rated down from an Outperform to a Perform. Analysts at Argus started covering the stock with ‘”a Buy”‘ outlook in a report released in late August. As of June 16, 2025, Truist has initiated its “Buy” rating for DXCM. Earlier on May 30, 2025, Goldman initiated its rating. Their recommendation was “a Buy” for DXCM stock.
Analyzing DXCM Stock Performance
On last trading session, Dexcom Inc [NASDAQ: DXCM] plunged -3.06% to $76.0. The stock’s lowest price that day was $75.56, but it reached a high of $78.28 in the same session. During the last five days, there has been a drop of approximately -3.70%. Over the course of the year, Dexcom Inc shares have jumped approximately 10.77%. Shares of the company reached a 52-week high of $93.25 on 02/18/25 and a 52-week low of $57.52 on 04/04/25.
Support And Resistance Levels for Dexcom Inc (DXCM)
According to the 24-hour chart, there is a support level at 74.94, which, if violated, would cause prices to drop to 73.89. In the upper region, resistance lies at 77.67. The next price resistance is at 79.34. RSI (Relative Strength Index) is 42.01 on the 14-day chart, showing neutral technical sentiment.
Is Dexcom Inc subject to short interest?
Stocks of Dexcom Inc saw a sharp rise in short interest on 2025-08-15 jumping by 1.0 million shares to 9.9 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 8.89 million shares. A jump of 10.15% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.7 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.7.
Which companies own the most shares of Dexcom Inc (DXCM)?
In terms of Dexcom Inc share price expectations, FactSet research, analysts set an average price target of 95 in the next 12 months, up nearly 21.17% from the previous closing price of $78.4. Analysts anticipate Dexcom Inc stock to reach 146 by 2025, with the lowest price target being 28.125. In spite of this, 12 analysts ranked Dexcom Inc stock as Buy at the end of 2025. On April 10, 2025, Mizuho assigned a price target of “an Outperform” to the stock and initiated coverage with a $85.
